Utility of Blood Cultures in Pneumonia
David Zhang1, Danny Yang2, Anil N Makam3
1Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas.
Introduction:
Blood cultures are of limited utility in nonsevere community-acquired pneumonia, though routinely recommended for severe community-acquired pneumonia or health care-associated pneumonia due to perceived greater bacteremia risk, particularly with multidrug-resistant organisms. The utility of this practice is unknown.
Methods:
In this observational cohort study, we abstracted data from medical records for consecutive hospitalizations for pneumonia by adults to an academic medical center from 2014-2015. The primary outcomes included bacteremia, multidrug-resistant organism bacteremia, and appropriate management changes attributed to culture results, stratified by pneumonia classification (nonsevere community-acquired pneumonia, severe community-acquired pneumonia, or health care-associated pneumonia) and likelihood the bacteremia was due to pneumonia vs another infection. We assessed the diagnostic test performance of one or more guideline-defined risk factors for bacteremia in nonsevere community-acquired pneumonia, for whom cultures are routinely recommended.
Results:
Of 456 pneumonia hospitalizations, 30 (6.6%) had bacteremia, with a greater incidence in severe community-acquired pneumonia (14.7%) than nonsevere community-acquired pneumonia (7.8%) and health care-associated pneumonia (6.6%; P = .12). Seventeen bacteremia cases were likely due to pneumonia (3.7%). Only 2 (0.4%) had multidrug-resistant organisms (both health care-associated pneumonia), one of whom was due to pneumonia. Appropriate management changes occurred in 8 cases (1.8%; 7 de-escalation and 1 escalation of antibiotics); only 1 with bacteremia likely due to pneumonia (de-escalation). The one case of appropriate antibiotic escalation occurred in a patient with vancomycin-resistant Enterococcus unrelated to pneumonia. Having one or more guideline-defined risk factors did not identify bacteremia in nonsevere community-acquired pneumonia (positive likelihood ratio, 1.10; 95% confidence interval, 0.61-1.99).
Conclusion:
Routine blood cultures in pneumonia have extremely low yield and utility irrespective of severity and risk.
Insights
Routine blood cultures for pneumonia, regardless of severity, show very low utility. This practice yields minimal benefits, even when patients present with risk factors for bacteremia.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Pulmonary Medicine
Background:
- Blood cultures are standard for severe community-acquired pneumonia (CAP) and healthcare-associated pneumonia (HAP) due to perceived bacteremia risk, especially with multidrug-resistant organisms (MDROs).
- The actual clinical utility of routine blood cultures in pneumonia management remains largely unexamined.
Purpose of the Study:
- To evaluate the utility of blood cultures in adult patients hospitalized with pneumonia.
- To assess the incidence of bacteremia, MDRO bacteremia, and impact on antibiotic management across different pneumonia types.
Main Methods:
- An observational cohort study analyzed medical records of 456 adult pneumonia hospitalizations from 2014-2015.
- Outcomes included bacteremia, MDRO bacteremia, and management changes attributed to culture results, stratified by pneumonia severity (non-severe CAP, severe CAP, HAP).
- Diagnostic performance of risk factors for bacteremia in non-severe CAP was assessed.
Main Results:
- Overall bacteremia incidence was 6.6%, with higher rates in severe CAP (14.7%) vs. non-severe CAP (7.8%) and HAP (6.6%).
- Only 3.7% of bacteremias were likely pneumonia-related; MDROs were rare (0.4%) and mostly unrelated to pneumonia.
- Appropriate antibiotic management changes occurred in only 1.8% of cases, with minimal impact from culture results.
Conclusions:
- Routine blood cultures in pneumonia patients demonstrate extremely low diagnostic yield and clinical utility.
- The practice offers minimal benefit across all pneumonia severities and patient risk profiles.
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:29Blood Flow